Affluent Medical

About:

Affluent Medical is develops innovative new-generation mini-invasive implants to restore essential physiological functions.

Website: https://www.affluentmedical.com/

Top Investors: Kreos Capital, Edwards Lifesciences

Description:

Affluent Medical develops innovative new-generation mini-invasive implants to restore essential physiological functions in these areas: - Kardiozis aims to prevent endoleaks and risks of recurrence of the abdominal aortic aneurysm allowing patients to live more serenely facing an unpredictable risk of breakage; - Kalios and Epygon aim to provide more physiological surgical treatments for the repair or replacement of the mitral valve of the heart. Kalios can treat residual post-operative leakage and recurrent mitral insufficiency without having to reoperate patients. Epygon is today the only developing transcatheter valve to restore natural blood flow and safeguard the left ventricle. - Finally, Artus is the first electronically activatable artificial sphincter to treat stress urinary incontinence in men and women.

Total Funding Amount:

20.5M EUR

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2011-01-01

Contact Email:

contact(AT)affluentmedical.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2024-07-15

IPO Status:

Public

Industries:

© 2025 bioDAO.ai